Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 48.00 | |
10 mg | In stock | $ 68.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 173.00 | |
100 mg | In stock | $ 278.00 | |
500 mg | In stock | $ 969.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 54.00 |
Description | SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier. |
Targets&IC50 | MEK2:0.22 μM, MEK1:0.18 μM |
Kinase Assay | The ligand binding competition assays are performed. Cytosolic cell extracts from Hepa-1 cells are generated by the resuspension of the cell pellets in HEDG buffer [25 mM Hepes, 1 mM EDTA, 1 mM dithiothreitol, and 10% (v/v) glycerol, pH 7.5] containing 0.4 mM leupeptin, 4 mg/mL aprotinin, and 0.3 mM phenylmethylsulfonyl fluoride, homogenization, and centrifugation at 100,000 g for 45 min. Aliquots of the supernatant (120 μg) are incubated at room temperature for 2 h with the indicated concentrations of Pifithrin-α in the presence of 3 nM [3H]TCDD in HEDG buffer. After incubation on ice with hydroxyapatite for 30 min, HEDG buffer with 0.5% Tween 80 is added. The samples are centrifuged, washed twice, resuspended in 0.2 mL of scintillation fluid, and subjected to scintillation counting. Nonspecific binding is determined using a 150-fold molar excess of TCDF and subtracted from the total binding to obtain the specific binding. The specific binding is reported relative to [3H]TCDD alone[2]. |
Synonyms | SL 327, SL-327 |
Molecular Weight | 335.35 |
Formula | C16H12F3N3S |
CAS No. | 305350-87-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33.5 mg/mL (100 mM)
Ethanol: 16.8 mg/mL (50 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SL327 305350-87-2 Cell Cycle/Checkpoint DNA Damage/DNA Repair MAPK MEK DNA/RNA Synthesis Mitogen-activated protein kinase kinase inhibit Inhibitor MAPKK SL 327 MAP2K SL-327 inhibitor